Recent advances in psychedelic neuroscience have revitalized scientific inquiry into the biological foundations of consciousness. Large-scale neuroimaging studies have consistently demonstrated that psychedelics increase functional integration across distributed brain networks while weakening the stability of normally dominant neural architectures associated with self referential processing and...
Altered states of consciousness range from psychotic disintegration to mystical union, with oceanic affectivity - experiences of ego dissolution, boundlessness, and affective merging - constituting a central feature. While such states can be induced by psychedelics, they also occur through trauma, meditative practices, or within compulsive addictive cycles. In addition, oceanic states may offer...
This scoping review aims to systematically map the neurobiological evidence for psychological and pharmacologically-assisted interventions for post-traumatic stress disorder (PTSD) published between 2020 and 2025. Grounded in the triple-network model (default mode network, salience network, and central executive network), the review will synthesize findings across a range of intervention types,...
Obsessive Compulsive Disorder (OCD) is a prevalent mental disorder, with a lifetime prevalence of 2-3%, characterized by intrusive thoughts (obsessions) and repetitive behaviors (compulsions). These thoughts and behaviors take up a significant amount of time, cause immense distress, and compromise the quality of life of those who suffer from OCD. In addition to psychological factors such as...
Abstract Psilocybin is a classic psychedelic drug known to alter subjective experience and elicit long-term psychological changes, enhancing cognitive flexibility and reducing rigid self-related beliefs. Combined with compassion motivational primes that involve generating mental representations of compassion, it may increase the potential for activating the care-affiliative motivational...
Classical psychedelics, like lysergic acid diethylamide (LSD), N,N-dimethyltryptamine (DMT), and psilocybin, can alter perception, emotion, and cognition, and have shown promise as 're-purposed' treatments for some psychiatric disorders. Recent trials have, e.g., demonstrated rapid and sustained symptom relief in treatment-resistant depression. While promising as a treatment, the...
Individual variability in psilocybin response is a major challenge for psychedelic-assisted therapy, with structural brain features potentially serving as predictive biomarkers. (Lewis et al. Biomedicines 8(2):34 2020) reported that rostral anterior cingulate cortex thickness predicted emotional experiences under psilocybin, suggesting cortical morphometry as a marker of psychedelic...
Psilocybin holds promise as a treatment for mental illnesses. One dose of psilocybin induces structural remodeling of dendritic spines in the medial frontal cortex in mice. The dendritic spines would be innervated by presynaptic neurons, but the sources of these inputs have not been identified. Here, using monosynaptic rabies tracing, we map the brain-wide distribution of inputs to frontal...
One of the most striking features of human consciousness is its ability to foster an ongoing, seemingly continuous stream of thought. Prior studies have provided valuable insights into the neural correlates of the content of thought (e.g., whether it is task related or not). However, independent of its content, the stream of thought can also be characterized by its dynamics—how it changes over...
Abstract Mind-body interventions offer promising avenues for improving physical and mental health, yet the comprehensive biological effects of increasingly popular mind-body retreat interventions remain poorly understood. The neural and molecular effects of a 7-day retreat intervention combining meditation, reconceptualization, and open-label placebo healing rituals are investigated in an...